Please assess the completion status of the following clinical trial:

Trial Title: Aldosterone Antagonism and Microvascular Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 40-65 years~* Caucasian~* Waist circumference \> 102 cm (men)/\> 88 cm (women)~* Triglycerides \> 1.7 mmol/L~* High-normal blood pressure (office blood pressure: 130/85 - 139/89 mm Hg) or stage I hypertension (office blood pressure: 140/90 mm Hg - 159/99 mm Hg; 24h ABPM: 125/80 - 149/89 mm Hg)~Exclusion Criteria:~* Cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, congestive heart failure, cardiac shunts, cardiac surgery, pulmonary hypertension, cardiac arrhythmias, family history of cardiac arrhythmias or sudden cardiac death)~* Diabetes mellitus/impaired glucose metabolism (fasting glucose values \> 5.6 mmol/L)~* Grade 2 or 3 hypertension (office blood pressure: \> 160/100 mm Hg; ABPM \> 150/90 mm Hg)~* Unstable or severe pulmonary disease~* Unstable or severe thyroid disorders~* Inflammatory diseases~* Alcohol use \> 2 U/day (women)/\> 3 U/day (men)~* Use of antihypertensive, lipid-lowering or glucose-lowering medications,~* Use of corticosteroids, medication known to inhibit or induce CYP3A4, lithium, and tricyclic antidepressants or antipsychotic medication, and regular use (weekly or several times a week) of NSAIDs~* Plasma potassium levels \< 3.2 mmol/L or \> 5 mmol/L~* eGFR \< 60 mL/min~* Impairment of hepatic function~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Eplerenone (Type: ACTIVE_COMPARATOR): Eplerenone 50 mg 1dd during four weeks
- Placebo (Type: PLACEBO_COMPARATOR): Eplerenone-matched placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).